Form 4: Edwards Lifesciences Executive Daveen Chopra Reports Stock Transactions
SEC Form 4 Filing
Daveen Chopra, CVP at Edwards Lifesciences, reports the vesting and subsequent disposal of shares related to performance-based restricted stock units.
Summary
- On May 3, 2024, Daveen Chopra disposed of 291 shares of common stock at a price of $85.06.
- On May 4, 2024, 4,713 shares vested from performance rights at $0, and 2,321 shares were disposed of at $85.25.
- Following these transactions, Chopra directly owns 24,851 shares of Edwards Lifesciences common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 05/04/2021 | Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. |
| 05/01/2024 | The Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024. |
| 05/03/2024 | Disposal of 291 shares of common stock. |
| 05/04/2024 | Vesting of 4,713 shares from performance rights and disposal of 2,321 shares of common stock. |
| 05/03/2028 | Expiration Date of Performance Rights |
| 05/06/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.